CRNX Insider Trading

Insider Ownership Percentage: 6.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $24,786,054.74

Crinetics Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Crinetics Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Crinetics Pharmaceuticals Share Price & Price History

Current Price: $33.28
Price Change: Price Decrease of -0.83 (-2.43%)
As of 03/7/2025 05:00 PM ET

This chart shows the closing price history over time for CRNX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Crinetics Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/3/2025Dana PizzutiInsiderSell5,000$39.07$195,350.0031,748View SEC Filing Icon  
11/22/2024Jeff E. KnightCOOSell501$56.52$28,316.5251,653View SEC Filing Icon  
10/3/2024Dana PizzutiInsiderSell14,375$54.63$785,306.2528,507View SEC Filing Icon  
9/26/2024Marc WilsonCFOSell25,000$51.11$1,277,750.00111,092View SEC Filing Icon  
9/10/2024Stephen F. BetzInsiderSell1,035$51.50$53,302.5068,576View SEC Filing Icon  
8/26/2024Stephen F. BetzInsiderSell3,000$53.19$159,570.0069,611View SEC Filing Icon  
7/25/2024Marc WilsonCFOSell19,056$53.88$1,026,737.28111,092View SEC Filing Icon  
7/25/2024Stephen F. BetzInsiderSell3,000$53.43$160,290.0075,611View SEC Filing Icon  
7/15/2024Jeff E. KnightCOOSell27,000$55.00$1,485,000.0051,653View SEC Filing Icon  
7/15/2024Marc WilsonCFOSell25,000$55.00$1,375,000.00111,092View SEC Filing Icon  
7/10/2024Stephen F. BetzInsiderSell3,000$48.55$145,650.0078,611View SEC Filing Icon  
7/5/2024James HassardInsiderSell15,000$44.08$661,200.0029,259View SEC Filing Icon  
7/3/2024Dana PizzutiInsiderSell14,375$44.87$645,006.2528,507View SEC Filing Icon  
6/28/2024Marc WilsonCFOSell32,129$43.61$1,401,145.69111,092View SEC Filing Icon  
6/26/2024Jeff E. KnightCOOSell956$44.38$42,427.2852,580View SEC Filing Icon  
6/24/2024Dana PizzutiInsiderSell9,500$45.73$434,435.0027,786View SEC Filing Icon  
6/21/2024James HassardInsiderSell15,000$44.66$669,900.0029,259View SEC Filing Icon  
6/10/2024Stephen F. BetzInsiderSell3,000$43.86$131,580.0083,643View SEC Filing Icon  
5/28/2024Stephen F. BetzInsiderSell3,000$47.49$142,470.0086,643View SEC Filing Icon  
5/10/2024Stephen F. BetzInsiderSell3,000$49.43$148,290.0089,643View SEC Filing Icon  
5/8/2024Richard Scott StruthersCEOSell107,448$49.40$5,307,931.20257,485View SEC Filing Icon  
4/15/2024Dana PizzutiInsiderSell14,375$44.47$639,256.2527,786View SEC Filing Icon  
4/4/2024Richard Scott StruthersCEOSell40,951$49.17$2,013,560.67237,835View SEC Filing Icon  
3/28/2024Stephanie OkeyDirectorSell17,500$46.38$811,650.006,000View SEC Filing Icon  
3/22/2024Jeff E. KnightCOOSell32,359$44.31$1,433,827.2952,580View SEC Filing Icon  
3/20/2024Dana PizzutiInsiderSell15,089$44.06$664,821.3427,786View SEC Filing Icon  
3/20/2024Matthew K. FustDirectorSell60,000$44.14$2,648,400.0018,536View SEC Filing Icon  
3/19/2024Marc WilsonCFOSell6,942$42.91$297,881.22110,630View SEC Filing Icon  
1/25/2024Stephen F. BetzInsiderSell3,000$37.26$111,780.0073,298View SEC Filing Icon  
1/10/2024Stephen F. BetzInsiderSell3,000$37.65$112,950.0076,298View SEC Filing Icon  
1/3/2024Dana PizzutiInsiderSell14,375$35.00$503,125.005,911View SEC Filing Icon  
1/2/2024Marc WilsonCFOSell10,000$35.47$354,700.0096,055View SEC Filing Icon  
12/26/2023Stephen F. BetzInsiderSell3,000$35.89$107,670.0079,298View SEC Filing Icon  
12/21/2023Dana PizzutiInsiderSell9,583$34.57$331,284.315,911View SEC Filing Icon  
12/11/2023Stephen F. BetzInsiderSell3,000$32.87$98,610.0082,298View SEC Filing Icon  
11/27/2023Stephen F. BetzInsiderSell3,000$31.84$95,520.0085,298View SEC Filing Icon  
11/3/2023Richard Scott StruthersCEOSell199,082$30.56$6,083,945.92135,522View SEC Filing Icon  
11/1/2023Marc WilsonCFOSell10,000$28.75$287,500.0095,601View SEC Filing Icon  
10/17/2023Alan Seth KrasnerInsiderSell7,000$30.00$210,000.0043,210View SEC Filing Icon  
7/13/2023Richard Scott StruthersCEOSell14,157$20.35$288,094.95630,805View SEC Filing Icon  
7/11/2023Richard Scott StruthersCEOSell24,384$20.14$491,093.76656,421View SEC Filing Icon  
6/20/2023Marc WilsonCFOSell30,922$19.97$617,512.3495,158View SEC Filing Icon  
6/16/2023Richard Scott StruthersCEOSell50,000$20.81$1,040,500.00680,805View SEC Filing Icon  
6/8/2023Coelho Rogerio VivaldiDirectorBuy5,000$22.06$110,300.005,000View SEC Filing Icon  
4/5/2023Dana PizzutiInsiderSell8,212$16.15$132,623.804,500View SEC Filing Icon  
1/25/2023Stephen F. BetzInsiderSell8,336$21.07$175,639.5267,815View SEC Filing Icon  
1/17/2023Stephen F. BetzInsiderSell3,126$18.00$56,268.0076,151View SEC Filing Icon  
12/15/2022Stephen F. BetzInsiderSell3,126$16.00$50,016.0082,403View SEC Filing Icon  
12/1/2022Stephen F. BetzInsiderSell3,126$17.84$55,767.8484,968View SEC Filing Icon  
11/15/2022Stephen F. BetzInsiderSell3,126$18.72$58,518.7288,094View SEC Filing Icon  
10/17/2022Stephen F. BetzInsiderSell3,126$17.73$55,423.9894,346View SEC Filing Icon  
10/3/2022Stephen F. BetzInsiderSell3,126$19.64$61,394.6497,472View SEC Filing Icon  
9/15/2022Stephen F. BetzInsiderSell4,168$21.01$87,569.68100,598View SEC Filing Icon  
9/7/2022Stephen F. BetzInsiderSell1,042$21.00$21,882.00104,766View SEC Filing Icon  
7/26/2022Jeff E. KnightCOOSell1,152$20.70$23,846.404,950View SEC Filing Icon  
7/13/2022Matthew K. FustDirectorSell5,700$20.96$119,472.0012,536View SEC Filing Icon  
5/2/2022Stephen F. BetzInsiderSell3,247$20.10$65,264.70107,598View SEC Filing Icon  
4/18/2022Perceptive Advisors LlcMajor ShareholderBuy157,515$22.22$3,499,983.305,321,032View SEC Filing Icon  
4/18/2022Stephen F. BetzInsiderSell5,664$25.81$146,187.84110,845View SEC Filing Icon  
4/13/2022Richard Scott StruthersCEOSell138,643$26.83$3,719,791.69730,805View SEC Filing Icon  
4/5/2022Richard Scott StruthersCEOSell21,357$25.34$541,186.3857,400View SEC Filing Icon  
4/4/2022Stephen F. BetzInsiderSell9,000$23.97$215,730.00116,509View SEC Filing Icon  
3/31/2022Stephen F. BetzInsiderSell4,164$21.06$87,693.84View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Crinetics Pharmaceuticals (NASDAQ:CRNX)

98.51% of Crinetics Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CRNX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Crinetics Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/28/2025Universal Beteiligungs und Servicegesellschaft mbH334,783$17.12M0.0%N/A0.361%Search for SEC Filing on Google Icon
2/20/2025Mackenzie Financial Corp5,422$0.28M0.0%+8.8%0.006%Search for SEC Filing on Google Icon
2/19/2025GF Fund Management CO. LTD.1,947$100K0.0%N/A0.002%Search for SEC Filing on Google Icon
2/18/2025Castleark Management LLC77,780$3.98M0.1%+6.1%0.084%Search for SEC Filing on Google Icon
2/17/2025UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC325,276$16.63M0.0%+19.7%0.351%Search for SEC Filing on Google Icon
2/17/2025Woodline Partners LP50,000$2.56M0.0%N/A0.054%Search for SEC Filing on Google Icon
2/17/2025Soleus Capital Management L.P.85,000$4.35M0.3%N/A0.092%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Advisers LP8,100$0.41M0.0%-63.8%0.009%Search for SEC Filing on Google Icon
2/17/2025State of Wyoming985$50K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/17/2025Tema Etfs LLC57,933$2.96M1.2%N/A0.062%Search for SEC Filing on Google Icon
2/17/2025Stempoint Capital LP317,060$16.21M4.0%+48.3%0.342%Search for SEC Filing on Google Icon
2/17/2025Rafferty Asset Management LLC81,257$4.16M0.0%-16.6%0.088%Search for SEC Filing on Google Icon
2/17/2025Point72 Asset Management L.P.2,788,939$142.60M0.3%+21.2%3.007%Search for SEC Filing on Google Icon
2/17/2025ProShare Advisors LLC29,089$1.49M0.0%+49.7%0.031%Search for SEC Filing on Google Icon
2/17/2025MPM Bioimpact LLC617,035$31.55M4.5%+17.3%0.665%Search for SEC Filing on Google Icon
2/17/2025Paradigm Biocapital Advisors LP1,910,761$97.70M3.4%-24.1%2.060%Search for SEC Filing on Google Icon
2/17/2025Parkman Healthcare Partners LLC51,133$2.61M0.3%-34.1%0.055%Search for SEC Filing on Google Icon
2/17/2025Nicholas Investment Partners LP127,283$6.51M0.6%+35.6%0.137%Search for SEC Filing on Google Icon
2/17/2025Nuveen Asset Management LLC527,792$26.99M0.0%+2.6%0.569%Search for SEC Filing on Google Icon
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 27,687$1.42M0.1%+12.1%0.030%Search for SEC Filing on Google Icon
2/17/2025Orbimed Advisors LLC999,000$51.08M1.1%-4.9%1.077%Search for SEC Filing on Google Icon
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.53,163$2.72M0.0%+14.5%0.057%Search for SEC Filing on Google Icon
2/17/2025Janus Henderson Group PLC2,795,441$142.90M0.1%+15.1%3.014%Search for SEC Filing on Google Icon
2/17/2025Ensign Peak Advisors Inc502,690$25.70M0.0%-18.5%0.542%Search for SEC Filing on Google Icon
2/17/2025Farallon Capital Management LLC4,075,098$208.36M1.1%+250.7%4.394%Search for SEC Filing on Google Icon
2/17/2025D. E. Shaw & Co. Inc.9,876$0.51M0.0%-85.0%0.011%Search for SEC Filing on Google Icon
2/17/2025Deutsche Bank AG211,314$10.80M0.0%-2.2%0.228%Search for SEC Filing on Google Icon
2/17/2025Driehaus Capital Management LLC6,141,014$313.99M2.6%+4.3%6.622%Search for SEC Filing on Google Icon
2/17/2025Duquesne Family Office LLC122,700$6.27M0.2%-60.3%0.132%Search for SEC Filing on Google Icon
2/17/2025Cresset Asset Management LLC7,224$0.37M0.0%-20.4%0.008%Search for SEC Filing on Google Icon
2/17/2025Brevan Howard Capital Management LP9,777$0.50M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE235,281$12.03M0.0%-15.4%0.254%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets15,259$0.78M0.0%-27.1%0.016%Search for SEC Filing on Google Icon
2/17/2025Ameriprise Financial Inc.355,174$18.16M0.0%+110.8%0.383%Search for SEC Filing on Google Icon
2/17/2025Algert Global LLC28,777$1.47M0.0%-32.7%0.031%Search for SEC Filing on Google Icon
2/17/2025Allostery Investments LP9,700$0.50M0.5%N/A0.010%Search for SEC Filing on Google Icon
2/17/2025Acuta Capital Partners LLC122,900$6.28M6.3%-6.7%0.133%Search for SEC Filing on Google Icon
2/14/2025Novo Holdings A S960,215$49.10M3.0%-4.0%1.035%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC7,404$0.38M0.0%-94.3%0.008%Search for SEC Filing on Google Icon
2/14/2025Schonfeld Strategic Advisors LLC445,946$22.80M0.1%-9.1%0.481%Search for SEC Filing on Google Icon
2/14/2025First Light Asset Management LLC885,453$45.27M4.3%-6.2%0.955%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp879,814$44.99M0.0%+20.4%0.949%Search for SEC Filing on Google Icon
2/14/2025The Manufacturers Life Insurance Company 148,956$7.62M0.0%+11.1%0.161%Search for SEC Filing on Google Icon
2/14/2025Decheng Capital LLC167,958$8.59M1.8%+6.3%0.181%Search for SEC Filing on Google Icon
2/14/2025Aquatic Capital Management LLC27,712$1.42M0.0%N/A0.030%Search for SEC Filing on Google Icon
2/14/2025Boothbay Fund Management LLC137,752$7.04M0.2%+25.9%0.149%Search for SEC Filing on Google Icon
2/14/2025Virtus ETF Advisers LLC1,279$65K0.0%-34.8%0.001%Search for SEC Filing on Google Icon
2/14/2025Gilder Gagnon Howe & Co. LLC25,044$1.28M0.0%+98.5%0.027%Search for SEC Filing on Google Icon
2/14/2025Lord Abbett & CO. LLC724,625$37.05M0.1%-2.9%0.781%Search for SEC Filing on Google Icon
2/14/2025Voya Investment Management LLC389,220$19.90M0.0%+0.1%0.420%Search for SEC Filing on Google Icon
2/14/2025Adage Capital Partners GP L.L.C.65,000$3.32M0.0%+62.5%0.070%Search for SEC Filing on Google Icon
2/14/2025Hood River Capital Management LLC851,400$43.53M0.6%+2.0%0.918%Search for SEC Filing on Google Icon
2/14/2025T. Rowe Price Investment Management Inc.1,002,882$51.28M0.0%-6.1%1.081%Search for SEC Filing on Google Icon
2/14/2025Price T Rowe Associates Inc. MD5,414,505$276.84M0.0%+9.5%5.838%Search for SEC Filing on Google Icon
2/14/2025Diadema Partners LP25,900$1.32M0.6%N/A0.028%Search for SEC Filing on Google Icon
2/14/2025Hsbc Holdings PLC12,552$0.65M0.0%+61.7%0.014%Search for SEC Filing on Google Icon
2/14/2025Rock Springs Capital Management LP294,100$15.04M0.6%+1.6%0.317%Search for SEC Filing on Google Icon
2/14/2025Tower Research Capital LLC TRC 7,412$0.38M0.0%+1,539.8%0.008%Search for SEC Filing on Google Icon
2/14/2025MetLife Investment Management LLC53,020$2.71M0.0%+18.0%0.057%Search for SEC Filing on Google Icon
2/14/2025First Trust Advisors LP195,821$10.01M0.0%-6.9%0.211%Search for SEC Filing on Google Icon
2/13/2025CANADA LIFE ASSURANCE Co19,219$0.98M0.0%+10.8%0.021%Search for SEC Filing on Google Icon
2/13/2025PEAK6 LLC10,000$0.51M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/13/2025Affinity Asset Advisors LLC460,000$23.52M3.1%+15.0%0.496%Search for SEC Filing on Google Icon
2/13/2025Guggenheim Capital LLC26,143$1.34M0.0%-7.2%0.028%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC181,941$9.30M0.0%-12.4%0.196%Search for SEC Filing on Google Icon
2/13/2025Summit Investment Advisors Inc.9,174$0.47M0.4%+16.4%0.010%Search for SEC Filing on Google Icon
2/13/2025Martingale Asset Management L P22,484$1.15M0.0%+1.9%0.024%Search for SEC Filing on Google Icon
2/13/2025Legal & General Group Plc88,939$4.55M0.0%+16.4%0.096%Search for SEC Filing on Google Icon
2/13/2025Invesco Ltd.298,254$15.25M0.0%+16.8%0.322%Search for SEC Filing on Google Icon
2/13/2025ADAR1 Capital Management LLC53,125$2.72M0.5%-39.9%0.057%Search for SEC Filing on Google Icon
2/13/2025FMR LLC8,928,086$456.49M0.0%+100.4%9.627%Search for SEC Filing on Google Icon
2/13/2025Russell Investments Group Ltd.34,200$1.75M0.0%-56.0%0.037%Search for SEC Filing on Google Icon
2/13/2025Envestnet Asset Management Inc.63,077$3.23M0.0%+16.1%0.068%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN100,916$5.16M0.0%+18.9%0.109%Search for SEC Filing on Google Icon
2/12/2025Cinctive Capital Management LP36,988$1.89M0.1%-25.2%0.040%Search for SEC Filing on Google Icon
2/12/2025Bryce Point Capital LLC22,686$1.16M0.3%N/A0.024%Search for SEC Filing on Google Icon
2/12/2025Headlands Technologies LLC1,022$52K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC2,098,841$107.34M0.0%+13.6%2.263%Search for SEC Filing on Google Icon
2/12/2025Franklin Resources Inc.1,591,666$81.38M0.0%+14.5%1.716%Search for SEC Filing on Google Icon
2/12/2025Alliancebernstein L.P.101,720$5.20M0.0%+9.9%0.110%Search for SEC Filing on Google Icon
2/12/2025Wellington Management Group LLP6,950,567$355.38M0.1%+55.9%7.495%Search for SEC Filing on Google Icon
2/12/2025Schroder Investment Management Group29,361$1.49M0.0%N/A0.032%Search for SEC Filing on Google Icon
2/12/2025Orion Portfolio Solutions LLC16,721$0.86M0.0%-8.3%0.018%Search for SEC Filing on Google Icon
2/12/2025Pictet Asset Management Holding SA848,050$43.36M0.0%-6.6%0.914%Search for SEC Filing on Google Icon
2/12/2025NEOS Investment Management LLC57,933$2.96M0.1%+0.9%0.062%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.269,543$13.78M0.0%-5.7%0.291%Search for SEC Filing on Google Icon
2/11/2025Pier Capital LLC111,999$5.73M0.8%+3.4%0.121%Search for SEC Filing on Google Icon
2/11/2025Segall Bryant & Hamill LLC150,398$7.69M0.1%N/A0.162%Search for SEC Filing on Google Icon
2/11/2025Prudential Financial Inc.277,370$14.18M0.0%+60.5%0.299%Search for SEC Filing on Google Icon
2/11/2025Corebridge Financial Inc.43,599$2.23M0.0%+4.8%0.047%Search for SEC Filing on Google Icon
2/11/2025Vanguard Group Inc.9,089,391$464.74M0.0%+44.6%9.801%Search for SEC Filing on Google Icon
2/11/2025LPL Financial LLC6,071$0.31M0.0%+23.7%0.007%Search for SEC Filing on Google Icon
2/11/2025KLP Kapitalforvaltning AS16,000$0.82M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/11/2025Sei Investments Co.55,727$2.85M0.0%-0.8%0.060%Search for SEC Filing on Google Icon
2/11/2025American Century Companies Inc.477,298$24.40M0.0%+23.4%0.515%Search for SEC Filing on Google Icon
2/11/2025Teacher Retirement System of Texas24,003$1.23M0.0%+42.8%0.026%Search for SEC Filing on Google Icon
2/11/2025Harvest Fund Management Co. Ltd1,299$66K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/11/2025Xponance Inc.6,284$0.32M0.0%+22.8%0.007%Search for SEC Filing on Google Icon
2/11/2025Intech Investment Management LLC43,105$2.20M0.1%+92.9%0.046%Search for SEC Filing on Google Icon
2/10/2025Cibc World Markets Corp8,206$0.42M0.0%N/A0.009%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Crinetics Pharmaceuticals logo
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in Phase 3 trial for the treatment of acromegaly; and Phase 2 trial for treating carcinoid syndrome associated with neuroendocrine tumors. It is also developing CRN04894, an investigational oral nonpeptide product candidate to antagonize the adrenocorticotrophic hormone (ACTH) receptor that has completed a Phase 1 study for the treatment of diseases caused by excess ACTH, including congenital adrenal hyperplasia and Cushing's disease. In addition, the company is developing antagonists of the parathyroid hormone (PTH) receptor for the treatment of primary hyperparathyroidism and humoral hypercalcemia of malignancy, and other diseases of excess PTH; identified investigational orally available somatostatin receptor type 3 targeted nonpeptide agonists for the treatment of autosomal dominant polycystic kidney disease; and developing thyroid-stimulating hormone receptor antagonists for the treatment of graves' disease and thyroid eye disease, as well as Oral GLP-1 and GIP nonpeptides for the treatment of diabetes and obesity. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
Read More on Crinetics Pharmaceuticals

Today's Range

Now: $33.28
Low: $32.63
High: $34.15

50 Day Range

MA: $39.58
Low: $32.30
High: $53.15

52 Week Range

Now: $33.28
Low: $31.84
High: $62.53

Volume

1,089,392 shs

Average Volume

1,034,054 shs

Market Capitalization

$3.10 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.58

Who are the company insiders with the largest holdings of Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals' top insider investors include:
  1. Richard Scott Struthers (CEO)
  2. Marc Wilson (CFO)
  3. Stephen F Betz (Insider)
  4. Jeff E Knight (COO)
  5. Alan Seth Krasner (Insider)
  6. Dana Pizzuti (Insider)
  7. James Hassard (Insider)
  8. Matthew K Fust (Director)
  9. Stephanie Okey (Director)
  10. Coelho Rogerio Vivaldi (Director)
Learn More about top insider investors at Crinetics Pharmaceuticals.

Who are the major institutional investors of Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals' top institutional investors include:
  1. Vanguard Group Inc. — 9.80%
  2. FMR LLC — 9.63%
  3. Wellington Management Group LLP — 7.49%
  4. Driehaus Capital Management LLC — 6.62%
  5. Price T Rowe Associates Inc. MD — 5.84%
  6. Farallon Capital Management LLC — 4.39%
Learn More about top institutional investors of Crinetics Pharmaceuticals stock.

Which institutional investors are selling Crinetics Pharmaceuticals stock?

During the previous quarter, CRNX stock was sold by these institutional investors:
  1. Paradigm Biocapital Advisors LP
  2. Duquesne Family Office LLC
  3. Jane Street Group LLC
  4. Ensign Peak Advisors Inc
  5. Jennison Associates LLC
  6. T. Rowe Price Investment Management Inc.
  7. Victory Capital Management Inc.
  8. Pictet Asset Management Holding SA
During the last year, company insiders that have sold Crinetics Pharmaceuticals company stock include:
  1. Richard Scott Struthers (CEO)
  2. Marc Wilson (CFO)
  3. Stephen F Betz (Insider)
  4. Jeff E Knight (COO)
  5. Alan Seth Krasner (Insider)
  6. Dana Pizzuti (Insider)
  7. James Hassard (Insider)
  8. Matthew K Fust (Director)
Learn More investors selling Crinetics Pharmaceuticals stock.

Which institutional investors are buying Crinetics Pharmaceuticals stock?

In the last quarter, CRNX stock was bought by institutional investors including:
  1. FMR LLC
  2. Farallon Capital Management LLC
  3. Vanguard Group Inc.
  4. Wellington Management Group LLP
  5. SG Americas Securities LLC
  6. Point72 Asset Management L.P.
  7. Price T Rowe Associates Inc. MD
  8. Janus Henderson Group PLC